Cullinan Therapeutics, Inc. (CGEM)
14.73
-0.22
(-1.47%)
USD |
NASDAQ |
Apr 16, 16:00
14.73
0.00 (0.00%)
After-Hours: 17:16
Cullinan Therapeutics EPS Diluted (Quarterly) : -0.8566 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| MacroGenics, Inc. | -0.2236 |
| Xencor, Inc. | -0.0892 |
| Nkarta, Inc. | -0.3702 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.71M |
| Total Expenses (Quarterly) | 50.71M |
| Enterprise Value | 529.65M |
| Earnings Yield | -25.28% |
| Normalized Earnings Yield | -25.28 |